{"product_id":"update-on-renal-replacement-therapy-in-the-icu","title":"Update on Renal Replacement Therapy in the ICU","description":"\u003cmeta charset=\"utf-8\"\u003e\n\u003cdiv\u003e\n\u003cmeta charset=\"utf-8\"\u003e \u003cmeta charset=\"utf-8\"\u003e\n\u003cp class=\"p1\"\u003e\u003cb\u003eEverything you can learn about renal replacement therapy in the ICU and the latest development in research from the world's top scientsits. Streaming is available on request.\u003c\/b\u003e\u003c\/p\u003e\n\u003cp class=\"p1\"\u003e\u003cb\u003eMore than 24 hours of content in english.\u003c\/b\u003e\u003c\/p\u003e\n\u003cp class=\"p1\"\u003e\u003cb\u003eProgram :\u003c\/b\u003e\u003c\/p\u003e\n\u003cp class=\"p1\"\u003eWelcome to Roma: Caput Mundi -\u003cspan\u003e \u003c\/span\u003e\u003cstrong\u003eM. Antonelli (Rome, Italy)\u003c\/strong\u003e\u003cbr\u003eWelcome to the meeting Renal failure in the ICU -\u003cspan\u003e \u003c\/span\u003e\u003cstrong\u003eJ-L. Vincent (Brussels, Belgium)\u003c\/strong\u003e\u003cbr\u003eEvolution of our technologies -\u003cspan\u003e \u003c\/span\u003e\u003cstrong\u003eC. Ronco (Vicenza, Italy)\u003c\/strong\u003e\u003cbr\u003ePlans for the meeting - faculty\u003c\/p\u003e\n\u003cp class=\"p1\"\u003eBasic Concepts :\u003c\/p\u003e\n\u003cp class=\"p1\"\u003eMechanisms of solute transport across membranes - C. Ronco (Vicenza, Italy)\u003cbr\u003ePrinciples of extracorporal circulation - Z. Ricci (Rome, Italy)\u003cbr\u003eVascular access - R. Bellomo (Melbourne, Australia)\u003cbr\u003eThe classical prescription of dialysis - P. Saudan (Geneva, Switzerland) \u003cbr\u003e\u003c\/p\u003e\n\u003cp class=\"p1\"\u003e\u003cstrong\u003eMonitoring and Control of Delivery\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp class=\"p1\"\u003ePre or post dilution - Monitoring of the extracorporeal circuit -\u003cspan\u003e \u003c\/span\u003e\u003cstrong\u003eZ. Ricci (Rome, Italy)\u003c\/strong\u003e\u003cbr\u003eControl of treatment delivery -\u003cspan\u003e \u003c\/span\u003e\u003cstrong\u003eD. Payen (Paris, France) \u003c\/strong\u003e\u003cbr\u003eOptimal ultrafiltration -\u003cspan\u003e \u003c\/span\u003e\u003cstrong\u003eJ. Prowle (London, UK)\u003c\/strong\u003e\u003cbr\u003eElectrolytes management -\u003cspan\u003e \u003c\/span\u003e\u003cstrong\u003eO. Joannes-Boyau (Bordeaux, France) \u003c\/strong\u003e\u003cbr\u003eHow can biomakers help ? \u003cbr\u003e\u003cstrong\u003eJ. Kellum (Pittsburgh, USA) \u003c\/strong\u003e\u003c\/p\u003e\n\u003cp class=\"p1\"\u003e\u003cstrong\u003eWhen to start ? When to stop ?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp class=\"p1\"\u003eWhen should we start RTT ? -\u003cspan\u003e \u003c\/span\u003e\u003cstrong\u003eJ. Kellum (Pittsburgh, USA)\u003c\/strong\u003e\u003cbr\u003eWhen should we stop RTT ? -\u003cspan\u003e \u003c\/span\u003e\u003cstrong\u003eP. Pickkers (Nijmegen, the Netherlands) \u003c\/strong\u003e\u003cbr\u003eRound Table Discussiopn -\u003cspan\u003e \u003c\/span\u003e\u003cstrong\u003eR Bellomo (Melbourne, Australia), J. Kellum (Pittsburgh, USA), C. Ronco (Vicenza, Italy), M. Joannidls (Innsbruck, Austria), P. Pickkers (Nikmegen, The Netherlands)\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp class=\"p1\"\u003e\u003cstrong\u003eModality Intermittent vs continuous RRT \u003c\/strong\u003e\u003c\/p\u003e\n\u003cp class=\"p1\"\u003eIntermittent RTT is OK -\u003cspan\u003e \u003c\/span\u003e\u003cstrong\u003eJ. Prowle (London, UK) \u003c\/strong\u003e\u003cbr\u003eI prefer continuous RRT -\u003cspan\u003e \u003c\/span\u003e\u003cstrong\u003eR. Bellomo (Melbourne, Australia) \u003c\/strong\u003e\u003cbr\u003eSLED may be the best option -\u003cspan\u003e \u003c\/span\u003e\u003cstrong\u003eM. Joannidis (Innsbruck, Austria)\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp class=\"p1\"\u003e\u003cstrong\u003eRRT in special situations \u003c\/strong\u003e\u003c\/p\u003e\n\u003cp class=\"p1\"\u003eRRT in neurologic crises -\u003cspan\u003e \u003c\/span\u003e\u003cstrong\u003eF. Taccone (Brussels, Belgium) \u003c\/strong\u003e\u003cbr\u003eRRT in cardiac failure -\u003cspan\u003e \u003c\/span\u003e\u003cstrong\u003eJ. Prowle (London, UK)\u003c\/strong\u003e\u003cbr\u003eRRT in respiratory failure -\u003cspan\u003e \u003c\/span\u003e\u003cstrong\u003eM. Joannidis (Innsbruck, Austria) \u003c\/strong\u003e\u003c\/p\u003e\n\u003cp class=\"p1\"\u003e\u003cstrong\u003eThe shortcomings \u003c\/strong\u003e\u003c\/p\u003e\n\u003cp class=\"p1\"\u003eFrequent problems -\u003cspan\u003e \u003c\/span\u003e\u003cstrong\u003eZ. Ricci (Rome, Italy) \u003c\/strong\u003e\u003cbr\u003eTemperature control: is it important ? -\u003cspan\u003e \u003c\/span\u003e\u003cstrong\u003eM. Joannidis (Innsbruck, Austria) \u003c\/strong\u003e\u003cbr\u003eElectrolyde disorders (Hypophophaternia, hypomagnesemia...) -\u003cspan\u003e \u003c\/span\u003e\u003cstrong\u003eD. Payen (Paris, France)\u003c\/strong\u003e\u003cbr\u003eAntibiotic therapy during RRT -\u003cspan\u003e \u003c\/span\u003e\u003cstrong\u003eM. Antonelli (Rome, Italy)F. Taciibe (Brussels, Belgium)\u003c\/strong\u003e\u003cbr\u003eElimination of other drugs -\u003cspan\u003e \u003c\/span\u003e\u003cstrong\u003eO. Joannes - Boyau (Bordeaux, France)\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp class=\"p1\"\u003e\u003cstrong\u003eAnticoagulation \u003c\/strong\u003e\u003c\/p\u003e\n\u003cp class=\"p1\"\u003eHeparins, heparinoids and direct thrombin inhibitors -\u003cspan\u003e \u003c\/span\u003e\u003cstrong\u003eM. Joannidis (Innsbruck, Austria)\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003e\u003cbr\u003eCitrate anticoagulation -\u003cspan\u003e \u003c\/span\u003e\u003cstrong\u003eP. Skeuden (Geneva, Switzerland) \u003c\/strong\u003e\u003cbr\u003eThe problems with citrate -\u003cspan\u003e \u003c\/span\u003e\u003cstrong\u003eO. Joannes-Boyau (Bordeaux, France)\u003c\/strong\u003e \u003cbr\u003eWhen to use one vs the other -\u003cspan\u003e \u003c\/span\u003e\u003cstrong\u003eD. De Backer (Brussels, Belgium)\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp class=\"p1\"\u003e\u003cstrong\u003eRemoval of bad humors \u003c\/strong\u003e\u003c\/p\u003e\n\u003cp class=\"p1\"\u003eIs there a rationale for RRT in sepsis ? -\u003cspan\u003e \u003c\/span\u003e\u003cstrong\u003eD. De Baker (Brussels, Belgium)\u003c\/strong\u003e\u003cbr\u003eCoupled plasma filtration -\u003cspan\u003e \u003c\/span\u003e\u003cstrong\u003eE. Turani (Rome, Italy)\u003c\/strong\u003e \u003cbr\u003ePolymoxin - B. hemoperfusion -\u003cspan\u003e \u003c\/span\u003e\u003cstrong\u003eM. Antonelli (Rome, Italy)\u003c\/strong\u003e\u003cbr\u003eMOST -\u003cspan\u003e \u003c\/span\u003e\u003cstrong\u003eC. Ronco (Vicenza, Italy) \u003c\/strong\u003e\u003c\/p\u003e\n\u003cp class=\"p1\"\u003e\u003cstrong\u003eHow to enhance treatment performance ? \u003c\/strong\u003e\u003c\/p\u003e\n\u003cp class=\"p1\"\u003eHigh volume is better - \u003cstrong\u003eC. Ronco (Vicenza, Italy) \u003c\/strong\u003e\u003cbr\u003eHigh permeability is better -\u003cspan\u003e \u003c\/span\u003e\u003cstrong\u003eR. Bellomo (Melbourne, Australia) \u003c\/strong\u003e\u003cbr\u003eHigh adsorption is better -\u003cspan\u003e \u003c\/span\u003e\u003cstrong\u003eJ. Kellum (Pittsburgh, USA)\u003c\/strong\u003e\u003cbr\u003e\u003c\/p\u003e\n\u003cp class=\"p1\"\u003e\u003cstrong\u003eRound table discussions \u003c\/strong\u003e\u003c\/p\u003e\n\u003cp class=\"p1\"\u003eVascular access -\u003cspan\u003e \u003c\/span\u003e\u003cstrong\u003eO. Joannes-Boyau (Bordeaux, France), D. Payen (Paris, France), E. Turani (Rome, Italy)F. Taccono (Brussels, Belgium)\u003c\/strong\u003e\u003cbr\u003eClooting and bleeding -\u003cspan\u003e \u003c\/span\u003e\u003cstrong\u003eM. Joannidia (Innsbruck, Austria), D. De Bakcer (Brussels, Belgium), R. Bellomo (Melbourne, Australia), P. Saudan (Geneva, Switzerland), O. Joannes-Boyau (Bordeaux, France) \u003c\/strong\u003e\u003cbr\u003eTechnical complications and troubleshooting -\u003cspan\u003e \u003c\/span\u003e\u003cstrong\u003eR. Bellomo (Melbourne, Australia), C. Ronco (Vicenz, Italy), Z. Ricci (Roma, Italy), P. Pickkers (Njimegen, the Netherlands)\u003c\/strong\u003e\u003cbr\u003eHow to guide fluid withdrawal - just by formula ? -\u003cspan\u003e \u003c\/span\u003e\u003cstrong\u003eM. Antonelli (Rome, Italy), D. De Becker (Brussels, Belgium), D. Payen (Paris, France), J. Prowle (London, UK)\u003c\/strong\u003e\u003cbr\u003eMy small tricks \u003cbr\u003eAll the faculty\u003c\/p\u003e\n\u003cp class=\"p1\"\u003e\u003cstrong\u003eConclusions \u003c\/strong\u003e\u003cbr\u003e\u003c\/p\u003e\n\u003cp class=\"p1\"\u003eThe take messages - Plans for publication\u003c\/p\u003e\n\u003c\/div\u003e","brand":"DVDCongress","offers":[{"title":"Default Title","offer_id":32482197241900,"sku":"","price":99.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0331\/9188\/6892\/products\/Rome-Renal.png?v=1585231184","url":"https:\/\/e-onescience.org\/products\/update-on-renal-replacement-therapy-in-the-icu","provider":"DVDCongress","version":"1.0","type":"link"}